Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency, Chronic × peginesatide × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Classical hematology 1

Conditions

Renal Insufficiency, Chronic 1 Neoplasms 1 Kidney Failure, Chronic 1 Anemia 1

Interventions

peginesatide 1 hematide 1 finerenone 1 empagliflozin 1 Standard of Care 1 Rocuronium 1 Practice Guidelines as Topic 1 Polymorphism, Genetic 1 Hypothermia, Induced 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00097747 2012-12-21

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

Affymax

Phase 1 Completed

Classical hematologyGenitourinary

Anemia, Kidney Failure, Chronic, Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡